MARKET DATA
Market Intelligence
Empowers investors with unparalleled accuracy and transparency into private market data and insights.
Your Single Source of Truth in Private Market Investing
Unlock the full potential of your investment strategy with CEPRES Market Intelligence, the premier platform for private market data and insights. Whether you're analyzing fund, direct, or operating company performance, CEPRES provides everything you need to support your stakeholders and make data-driven decisions.
Access insights from over 13,000 funds and 130,000 portfolio companies, enabling you to prove your investment thesis, develop portfolio strategies, and mitigate systematic risks with confidence.
CEPRES works directly with GPs to source the data you need to meet your portfolio goals. We verify every data point, down to individual operating cash flows, ensuring that 100% of your data is accurate, actionable and governed.
With more than 13,000 funds and 1,000,000 cash flows, CEPRES provides the most accurate, actionable private market data.
Leverage 50+ years of portfolio company cash flow performance as empirical evidence to make more informed investment decisions.
Comprehensive Analysis
Measure a GP's track record or benchmark your portfolio's performance against broader private and public markets. Move beyond traditional benchmarking by comparing your performance against real marketplace metrics, such as IRR, MOIC, alpha, TVPI, and operational KPIs like revenue CAGR and EBITDA growth. CEPRES empowers you to create, test, and refine your investment strategies, accelerating your impact in an increasingly complex private market landscape. Some types of analysis you can conduct with CEPRES Market Intelligence:
Market Intelligence Solutions
Benchmarking
Accurate, verified GP cash flow analysis at the fund and deal level for deeper insights into the true drivers of portfolio risk, return, and value
Market Research
Customized analysis to research and model private market investment strategies
Benchmarking
Accurate, verified GP cash flow analysis at the fund and deal level for deeper insights into the true drivers of portfolio risk, return, and value
Market Research
Customized analysis to research and model private market investment strategies
Featured Content
The PE industry has grown rapidly over the last two decades, recording an extraordinary increase in funds raised, fund size, deal volume, and overall deal size. But a perennial challenge – illiquidity – has remained largely unresolved, until now.
The Solactive CEPRES US Private Equity Industry Replicator Index is a new approach that provides return exposure to the return profile of buyout funds focused on North America.
This new replication approach, based on reweighting publicly listed equities, can deliver a similar performance to the North American private equity sector.
Insights
Private Debt at a Crossroads: Navigating Stress, Dispersion, and the Data Advantage
U.S. private credit defaults hit a record 6.0%, distressed PIK deferrals reached 6.4% of private debt volume, and 2021–2022 vintages are exposing sharp gaps in default, loss, and recovery rates. Based on CEPRES data across 1,230+ private debt funds, this report shows where stress is concentrated by vintage, geography, sector, and fund structure — helping institutional investors sharpen manager selection, pressure-test allocations, and identify risk before it is hidden in headline performance.
The Repricing of Private Markets: 25 Years of Data on Valuations, Leverage and Returns
LPs cannot afford to rely on outdated assumptions.
Pricing has shifted. Leverage risk is rising. Returns are under pressure. In today’s volatile market, understanding where private markets have been repriced is critical to manager selection, underwriting, and portfolio risk.
Based on 172,000+ private market deals, this whitepaper reveals how valuations, leverage, and returns have changed — including deeper analysis of North American buyouts and Software.
Download the whitepaper to see where risk is building before it shows up in your portfolio.
How Deal Comps Can Help Uncover Hidden Opportunities and Avoid Costly Mistakes
This report uses granular Deal Comps from CEPRES DealForge to reveal two very different healthcare subsector stories: cosmetic dental implants, where median gross IRR reaches 21.8% with ~10.1x entry EV/EBITDA, and mental care facilities, where nearly one-third of deals fall below 1.0x MOIC.
Download the report to see how deal-level benchmarks can help GPs identify overlooked niches, pressure-test entry pricing, uncover hidden margin risk, and make sharper underwriting decisions before capital is at stake.
Private Debt at a Crossroads: Navigating Stress, Dispersion, and the Data Advantage
U.S. private credit defaults hit a record 6.0%, distressed PIK deferrals reached 6.4% of private debt volume, and 2021–2022 vintages are exposing sharp gaps in default, loss, and recovery rates. Based on CEPRES data across 1,230+ private debt funds, this report shows where stress is concentrated by vintage, geography, sector, and fund structure — helping institutional investors sharpen manager selection, pressure-test allocations, and identify risk before it is hidden in headline performance.
The Repricing of Private Markets: 25 Years of Data on Valuations, Leverage and Returns
LPs cannot afford to rely on outdated assumptions.
Pricing has shifted. Leverage risk is rising. Returns are under pressure. In today’s volatile market, understanding where private markets have been repriced is critical to manager selection, underwriting, and portfolio risk.
Based on 172,000+ private market deals, this whitepaper reveals how valuations, leverage, and returns have changed — including deeper analysis of North American buyouts and Software.
Download the whitepaper to see where risk is building before it shows up in your portfolio.
How Deal Comps Can Help Uncover Hidden Opportunities and Avoid Costly Mistakes
This report uses granular Deal Comps from CEPRES DealForge to reveal two very different healthcare subsector stories: cosmetic dental implants, where median gross IRR reaches 21.8% with ~10.1x entry EV/EBITDA, and mental care facilities, where nearly one-third of deals fall below 1.0x MOIC.
Download the report to see how deal-level benchmarks can help GPs identify overlooked niches, pressure-test entry pricing, uncover hidden margin risk, and make sharper underwriting decisions before capital is at stake.